232 related articles for article (PubMed ID: 37240071)
1. Butyrophilins: Dynamic Regulators of Protective T Cell Immunity in Cancer.
Kumari R; Hosseini ES; Warrington KE; Milonas T; Payne KK
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240071
[TBL] [Abstract][Full Text] [Related]
2. Heteromeric interactions regulate butyrophilin (BTN) and BTN-like molecules governing γδ T cell biology.
Vantourout P; Laing A; Woodward MJ; Zlatareva I; Apolonia L; Jones AW; Snijders AP; Malim MH; Hayday AC
Proc Natl Acad Sci U S A; 2018 Jan; 115(5):1039-1044. PubMed ID: 29339503
[TBL] [Abstract][Full Text] [Related]
3. Butyrophilins: γδ T Cell Receptor Ligands, Immunomodulators and More.
Herrmann T; Karunakaran MM
Front Immunol; 2022; 13():876493. PubMed ID: 35371078
[TBL] [Abstract][Full Text] [Related]
4. Butyrophilin-like 3 Directly Binds a Human Vγ4
Willcox CR; Vantourout P; Salim M; Zlatareva I; Melandri D; Zanardo L; George R; Kjaer S; Jeeves M; Mohammed F; Hayday AC; Willcox BE
Immunity; 2019 Nov; 51(5):813-825.e4. PubMed ID: 31628053
[TBL] [Abstract][Full Text] [Related]
5. The Juxtamembrane Domain of Butyrophilin BTN3A1 Controls Phosphoantigen-Mediated Activation of Human Vγ9Vδ2 T Cells.
Peigné CM; Léger A; Gesnel MC; Konczak F; Olive D; Bonneville M; Breathnach R; Scotet E
J Immunol; 2017 Jun; 198(11):4228-4234. PubMed ID: 28461569
[TBL] [Abstract][Full Text] [Related]
6. Unsynchronized butyrophilin molecules dictate cancer cell evasion of Vγ9Vδ2 T-cell killing.
Wu Z; Lamao Q; Gu M; Jin X; Liu Y; Tian F; Yu Y; Yuan P; Gao S; Fulford TS; Uldrich AP; Wong CC; Wei W
Cell Mol Immunol; 2024 Apr; 21(4):362-373. PubMed ID: 38374404
[TBL] [Abstract][Full Text] [Related]
7. Butyrophilin 2A1 is essential for phosphoantigen reactivity by γδ T cells.
Rigau M; Ostrouska S; Fulford TS; Johnson DN; Woods K; Ruan Z; McWilliam HEG; Hudson C; Tutuka C; Wheatley AK; Kent SJ; Villadangos JA; Pal B; Kurts C; Simmonds J; Pelzing M; Nash AD; Hammet A; Verhagen AM; Vairo G; Maraskovsky E; Panousis C; Gherardin NA; Cebon J; Godfrey DI; Behren A; Uldrich AP
Science; 2020 Feb; 367(6478):. PubMed ID: 31919129
[TBL] [Abstract][Full Text] [Related]
8. ABCA1, apoA-I, and BTN3A1: A Legitimate Ménage à Trois in Dendritic Cells.
Riganti C; Castella B; Massaia M
Front Immunol; 2018; 9():1246. PubMed ID: 29937767
[TBL] [Abstract][Full Text] [Related]
9. New Insights Into the Regulation of γδ T Cells by BTN3A and Other BTN/BTNL in Tumor Immunity.
Blazquez JL; Benyamine A; Pasero C; Olive D
Front Immunol; 2018; 9():1601. PubMed ID: 30050536
[TBL] [Abstract][Full Text] [Related]
10. BTN2A1, an immune checkpoint targeting Vγ9Vδ2 T cell cytotoxicity against malignant cells.
Cano CE; Pasero C; De Gassart A; Kerneur C; Gabriac M; Fullana M; Granarolo E; Hoet R; Scotet E; Rafia C; Herrmann T; Imbert C; Gorvel L; Vey N; Briantais A; le Floch AC; Olive D
Cell Rep; 2021 Jul; 36(2):109359. PubMed ID: 34260935
[TBL] [Abstract][Full Text] [Related]
11. Vγ9+Vδ2+ T cell control of Listeria monocytogenes growth in infected epithelial cells requires butyrophilin 3A genes.
Fischer K; Bradlerova M; Decker T; Supper V
Sci Rep; 2023 Oct; 13(1):18651. PubMed ID: 37903831
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of Butyrophilin (
Lebrero-Fernández C; Wenzel UA; Akeus P; Wang Y; Strid H; Simrén M; Gustavsson B; Börjesson LG; Cardell SL; Öhman L; Quiding-Järbrink M; Bas-Forsberg A
Immun Inflamm Dis; 2016 Jun; 4(2):191-200. PubMed ID: 27957327
[TBL] [Abstract][Full Text] [Related]
13. Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.
Laplagne C; Ligat L; Foote J; Lopez F; Fournié JJ; Laurent C; Valitutti S; Poupot M
Cell Mol Immunol; 2021 Aug; 18(8):1861-1870. PubMed ID: 34183807
[TBL] [Abstract][Full Text] [Related]
14. [Butyrophilin 3A1 (BTN3A1) enhances activation and proliferation of human peripheral blood Vγ9Vδ2 T cells induced by MTB-HAg].
Tang J; Sun J; Zha C; Chang J; Hu K; Fang Q; Chen Y; Chen J; Li B
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Aug; 36(8):680-686. PubMed ID: 32958123
[TBL] [Abstract][Full Text] [Related]
15. Butyrophilin-like proteins display combinatorial diversity in selecting and maintaining signature intraepithelial γδ T cell compartments.
Jandke A; Melandri D; Monin L; Ushakov DS; Laing AG; Vantourout P; East P; Nitta T; Narita T; Takayanagi H; Feederle R; Hayday A
Nat Commun; 2020 Jul; 11(1):3769. PubMed ID: 32724083
[TBL] [Abstract][Full Text] [Related]
16. Phosphoantigens glue butyrophilin 3A1 and 2A1 to activate Vγ9Vδ2 T cells.
Yuan L; Ma X; Yang Y; Qu Y; Li X; Zhu X; Ma W; Duan J; Xue J; Yang H; Huang JW; Yi S; Zhang M; Cai N; Zhang L; Ding Q; Lai K; Liu C; Zhang L; Liu X; Yao Y; Zhou S; Li X; Shen P; Chang Q; Malwal SR; He Y; Li W; Chen C; Chen CC; Oldfield E; Guo RT; Zhang Y
Nature; 2023 Sep; 621(7980):840-848. PubMed ID: 37674084
[TBL] [Abstract][Full Text] [Related]
17. Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2
Lai AY; Patel A; Brewer F; Evans K; Johannes K; González LE; Yoo KJ; Fromm G; Wilson K; Schreiber TH; de Silva S
J Immunol; 2022 Oct; 209(8):1475-1480. PubMed ID: 36096643
[TBL] [Abstract][Full Text] [Related]
18. BTN3A1 governs antitumor responses by coordinating αβ and γδ T cells.
Payne KK; Mine JA; Biswas S; Chaurio RA; Perales-Puchalt A; Anadon CM; Costich TL; Harro CM; Walrath J; Ming Q; Tcyganov E; Buras AL; Rigolizzo KE; Mandal G; Lajoie J; Ophir M; Tchou J; Marchion D; Luca VC; Bobrowicz P; McLaughlin B; Eskiocak U; Schmidt M; Cubillos-Ruiz JR; Rodriguez PC; Gabrilovich DI; Conejo-Garcia JR
Science; 2020 Aug; 369(6506):942-949. PubMed ID: 32820120
[TBL] [Abstract][Full Text] [Related]
19. Targeting butyrophilins for cancer immunotherapy.
Rigau M; Uldrich AP; Behren A
Trends Immunol; 2021 Aug; 42(8):670-680. PubMed ID: 34253468
[TBL] [Abstract][Full Text] [Related]
20. BTN3A1 Discriminates γδ T Cell Phosphoantigens from Nonantigenic Small Molecules via a Conformational Sensor in Its B30.2 Domain.
Salim M; Knowles TJ; Baker AT; Davey MS; Jeeves M; Sridhar P; Wilkie J; Willcox CR; Kadri H; Taher TE; Vantourout P; Hayday A; Mehellou Y; Mohammed F; Willcox BE
ACS Chem Biol; 2017 Oct; 12(10):2631-2643. PubMed ID: 28862425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
